1353246-63-5

Basic information

• Product Name: N-[(3R)-1-(2-fluoro-6-methoxybenzyl)piperidin-3-yl]-3-(1H-imidazol-5-yl)-1H-indazol-5-carboxamide
• Synonyms: N-[(3R)-1-(2-fluoro-6-methoxybenzyl)piperidin-3-yl]-3-(1H-imidazol-5-yl)-1H-indazol-5-carboxamide
• CAS NO: 1353246-63-5
• Molecular Weight: 448.5
• Mol File: 1353246-63-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-[(3R)-1-(2-fluoro-6-methoxybenzyl)piperidin-3-yl]-3-(1H-imidazol-5-yl)-1H-indazol-5-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[(3R)-1-(2-fluoro-6-methoxybenzyl)piperidin-3-yl]-3-(1H-imidazol-5-yl)-1H-indazol-5-carboxamide(1353246-63-5)
• EPA Substance Registry System: N-[(3R)-1-(2-fluoro-6-methoxybenzyl)piperidin-3-yl]-3-(1H-imidazol-5-yl)-1H-indazol-5-carboxamide(1353246-63-5)

Safety Data

• Hazardous Substances Data: 1353246-63-5(Hazardous Substances Data)

Upstream product

• 1353255-21-6 3-bromo-N-[(3R)-1-(2-fluoro-6-methoxybenzyl)piperidin-3-yl]-1-trityl-1H-indazole-5-carboxamide 
• 101226-33-9 1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazole 

Relevant articles and documents

NOVEL HETEROCYCLIC COMPOUNDS AS ERK INHIBITORS

The present invention provides a compound of the Formula I:(Formular I should be inserted here) or a pharmaceutically acceptable salt, solvate or ester thereof, wherein R, R1, R2 and R3 are as defined herein. The compounds are ERK inhibitors. Also disclosed are pharmaceutical compositions comprising the above compounds and methods of treating cancer using the same.